| Position | Group Leader of the Laboratory of Cellular Senescence and Age-related Pathologies |
| Research fields | Cellular Senecence, DNA damage, SASP, skin, aging, cancer, metastasis, chemotherapy, tissue repair, wound healing |
Dr. Marco Demaria is Professor of Cellular Ageing and Senescence at the University Medical Center Groningen (UMCG), where he serves as Director of the Institute for Mechanisms of Health, Ageing and Disease (MoHAD) and leads the Laboratory of Cellular Senescence and Age-Related Pathologies at the European Research Institute for the Biology of Ageing (ERIBA). He obtained his PhD in Molecular Medicine at the University of Torino, Italy, under the supervision of Prof. Valeria Poli, investigating the role of chronic inflammation and cellular metabolism in tumor progression.
In 2010, he joined the Buck Institute for Research on Aging in California, USA, as a postdoctoral fellow in the laboratory of Prof. Judith Campisi. There, he developed innovative tools and models to study senescent cells in vivo and contributed to defining their roles in tissue repair, cancer, and aging. He also initiated translational work on therapeutic strategies to target senescent cells in order to extend healthspan.
Since 2015, Dr. Demaria has been a faculty member at UMCG and ERIBA, where his laboratory focuses on identifying molecular mechanisms and biomarkers of cellular senescence, as well as characterizing the detrimental effects of senescent cells during aging and following cancer therapies. A central aim of his research is to leverage these insights for the development of rejuvenating interventions.
Beyond academia, he co-founded Cleara Biotech in 2018, a biotechnology company developing drugs that selectively target senescent cells. Dr. Demaria currently serves as Editor-in-Chief of Aging-US and he is the President of the International Cell Senescence Association (ICSA).
Update your browser to view this website correctly. Update my browser now